
Amanda L. Aguirre
Examiner (ID: 17942, Phone: (571)272-5592 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1626 |
| Total Applications | 850 |
| Issued Applications | 613 |
| Pending Applications | 94 |
| Abandoned Applications | 188 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18842487
[patent_doc_number] => 20230404891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => COMPOSITION FOR SKINCARE
[patent_app_type] => utility
[patent_app_number] => 18/250308
[patent_app_country] => US
[patent_app_date] => 2020-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3734
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18250308
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/250308 | COMPOSITION FOR SKINCARE | Oct 29, 2020 | Pending |
Array
(
[id] => 18842487
[patent_doc_number] => 20230404891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => COMPOSITION FOR SKINCARE
[patent_app_type] => utility
[patent_app_number] => 18/250308
[patent_app_country] => US
[patent_app_date] => 2020-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3734
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18250308
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/250308 | COMPOSITION FOR SKINCARE | Oct 29, 2020 | Pending |
Array
(
[id] => 19871298
[patent_doc_number] => 12264142
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-01
[patent_title] => Heterocyclic compounds
[patent_app_type] => utility
[patent_app_number] => 17/755103
[patent_app_country] => US
[patent_app_date] => 2020-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13935
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17755103
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/755103 | Heterocyclic compounds | Oct 20, 2020 | Issued |
Array
(
[id] => 18065469
[patent_doc_number] => 20220396556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => Lipid and Lipid Nanoparticle Formulation for Drug Delivery
[patent_app_type] => utility
[patent_app_number] => 17/769858
[patent_app_country] => US
[patent_app_date] => 2020-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32981
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -48
[patent_words_short_claim] => 300
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17769858
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/769858 | Lipid and Lipid Nanoparticle Formulation for Drug Delivery | Oct 18, 2020 | Pending |
Array
(
[id] => 16612089
[patent_doc_number] => 20210030742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => Methods for the Administration of Certain VMAT2 Inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/073304
[patent_app_country] => US
[patent_app_date] => 2020-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18074
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17073304
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/073304 | Methods for the administration of certain VMAT2 inhibitors | Oct 16, 2020 | Issued |
Array
(
[id] => 17928332
[patent_doc_number] => 20220323457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => MODULATORS OF BCL6 PROTEOLYSIS AND ASSOCIATED METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/073135
[patent_app_country] => US
[patent_app_date] => 2020-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 77229
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17073135
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/073135 | Modulators of BCL6 proteolysis and associated methods of use | Oct 15, 2020 | Issued |
Array
(
[id] => 19097643
[patent_doc_number] => 20240116871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES
[patent_app_type] => utility
[patent_app_number] => 17/768508
[patent_app_country] => US
[patent_app_date] => 2020-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10347
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17768508
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/768508 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | Oct 12, 2020 | Pending |
Array
(
[id] => 17572111
[patent_doc_number] => 11320376
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-03
[patent_title] => Duplex stabilizing fluorescence quenchers for nucleic acid probes
[patent_app_type] => utility
[patent_app_number] => 17/066623
[patent_app_country] => US
[patent_app_date] => 2020-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 32
[patent_no_of_words] => 24000
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17066623
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/066623 | Duplex stabilizing fluorescence quenchers for nucleic acid probes | Oct 8, 2020 | Issued |
Array
(
[id] => 17200014
[patent_doc_number] => 20210340109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => METABOLICALLY STABLE 5-HMF DERIVATIVES FOR THE TREATMENT OF HYPOXIA
[patent_app_type] => utility
[patent_app_number] => 17/064998
[patent_app_country] => US
[patent_app_date] => 2020-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12068
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17064998
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/064998 | Metabolically stable 5-HMF derivatives for the treatment of hypoxia | Oct 6, 2020 | Issued |
Array
(
[id] => 18353951
[patent_doc_number] => 11642335
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-09
[patent_title] => Chemical synthesis of clopidogrel active metabolites and disulfide conjugate prodrugs
[patent_app_type] => utility
[patent_app_number] => 17/034228
[patent_app_country] => US
[patent_app_date] => 2020-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 20
[patent_no_of_words] => 5469
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17034228
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/034228 | Chemical synthesis of clopidogrel active metabolites and disulfide conjugate prodrugs | Sep 27, 2020 | Issued |
Array
(
[id] => 18056325
[patent_doc_number] => 20220387411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => TARGETED AUTOPHAGY CONJUGATES AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/763156
[patent_app_country] => US
[patent_app_date] => 2020-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 101098
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -124
[patent_words_short_claim] => 754
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17763156
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/763156 | TARGETED AUTOPHAGY CONJUGATES AND METHODS | Sep 22, 2020 | Pending |
Array
(
[id] => 19369122
[patent_doc_number] => 12061201
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-13
[patent_title] => Fluorescent probes for the visualization of FtsZ in gram-positive and gram-negative bacterial pathogens
[patent_app_type] => utility
[patent_app_number] => 17/027513
[patent_app_country] => US
[patent_app_date] => 2020-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12694
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17027513
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/027513 | Fluorescent probes for the visualization of FtsZ in gram-positive and gram-negative bacterial pathogens | Sep 20, 2020 | Issued |
Array
(
[id] => 16557103
[patent_doc_number] => 20210002251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => Bruton's Tyrosine Kinase Inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/025026
[patent_app_country] => US
[patent_app_date] => 2020-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56447
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17025026
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/025026 | Bruton's Tyrosine Kinase Inhibitors | Sep 17, 2020 | Abandoned |
Array
(
[id] => 17414198
[patent_doc_number] => 20220049102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => Process for the Purification of Methylene Blue
[patent_app_type] => utility
[patent_app_number] => 17/023544
[patent_app_country] => US
[patent_app_date] => 2020-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5145
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17023544
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/023544 | Process for the purification of methylene blue | Sep 16, 2020 | Issued |
Array
(
[id] => 18271693
[patent_doc_number] => 20230092935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => CERIUM (IV) COMPLEXES AND THEIR USE IN ORGANIC ELECTRONICS
[patent_app_type] => utility
[patent_app_number] => 17/641129
[patent_app_country] => US
[patent_app_date] => 2020-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13085
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17641129
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/641129 | CERIUM (IV) COMPLEXES AND THEIR USE IN ORGANIC ELECTRONICS | Sep 6, 2020 | Pending |
Array
(
[id] => 20212518
[patent_doc_number] => 12409152
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-09
[patent_title] => Compositions and methods related to dissolved oxides
[patent_app_type] => utility
[patent_app_number] => 17/639280
[patent_app_country] => US
[patent_app_date] => 2020-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3605
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 407
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17639280
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/639280 | Compositions and methods related to dissolved oxides | Aug 27, 2020 | Issued |
Array
(
[id] => 20212518
[patent_doc_number] => 12409152
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-09
[patent_title] => Compositions and methods related to dissolved oxides
[patent_app_type] => utility
[patent_app_number] => 17/639280
[patent_app_country] => US
[patent_app_date] => 2020-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3605
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 407
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17639280
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/639280 | Compositions and methods related to dissolved oxides | Aug 27, 2020 | Issued |
Array
(
[id] => 16511506
[patent_doc_number] => 20200390763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => BENZENESULFONAMIDE DERIVATIVES OF QUINOXALINE, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE IN METHODS FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 17/003918
[patent_app_country] => US
[patent_app_date] => 2020-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25185
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -59
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17003918
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/003918 | BENZENESULFONAMIDE DERIVATIVES OF QUINOXALINE, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE IN METHODS FOR TREATING CANCER | Aug 25, 2020 | Abandoned |
Array
(
[id] => 18233188
[patent_doc_number] => 11597737
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-07
[patent_title] => Small molecule inhibitors selective for polo-like kinase proteins
[patent_app_type] => utility
[patent_app_number] => 17/001167
[patent_app_country] => US
[patent_app_date] => 2020-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 14
[patent_no_of_words] => 7157
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17001167
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/001167 | Small molecule inhibitors selective for polo-like kinase proteins | Aug 23, 2020 | Issued |
Array
(
[id] => 17821488
[patent_doc_number] => 11426411
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-30
[patent_title] => Cycloalkyl-diamines for the treatment of inflammation
[patent_app_type] => utility
[patent_app_number] => 16/997146
[patent_app_country] => US
[patent_app_date] => 2020-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6829
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 251
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16997146
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/997146 | Cycloalkyl-diamines for the treatment of inflammation | Aug 18, 2020 | Issued |